{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T17:23:46Z","timestamp":1772731426148,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,5]]},"DOI":"10.7759\/cureus.104717","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:27:43Z","timestamp":1772728063000},"source":"Crossref","is-referenced-by-count":0,"title":["Pacemaker Lead-Associated Innominate Vein Thrombosis Despite Non-vitamin K Oral Anticoagulant (NOAC) Therapy: An Incidental CT Finding"],"prefix":"10.7759","author":[{"given":"Neeraj","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Hallam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaw Nyein","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harriet","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Mahmud","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-005-1140-1","article-title":"Venous thrombosis and stenosis after implantation of pacemakers and defibrillators","volume":"13","author":"Rozmus G","year":"2005","unstructured":"Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J Interv Card Electrophysiol. 2005, 13:9-19. 10.1007\/s10840-005-1140-1","journal-title":"J Interv Card Electrophysiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eupc.2003.09.001","article-title":"Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement","volume":"6","author":"Lickfett L","year":"2004","unstructured":"Lickfett L, Bitzen A, Arepally A, et al.. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace. 2004, 6:25-31. 10.1016\/j.eupc.2003.09.001","journal-title":"Europace"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.698336","article-title":"Upper extremity deep vein thrombosis and asymptomatic vein occlusion in patients with transvenous leads: a systematic review and meta-analysis","volume":"8","author":"Duijzer D","year":"2021","unstructured":"Duijzer D, de Winter MA, Nijkeuter M, Tuinenburg AE, Westerink J. Upper extremity deep vein thrombosis and asymptomatic vein occlusion in patients with transvenous leads: a systematic review and meta-analysis. Front Cardiovasc Med. 2021, 8:698336. 10.3389\/fcvm.2021.698336","journal-title":"Front Cardiovasc Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1008740","article-title":"Clinical practice. Deep-vein thrombosis of the upper extremities","volume":"364","author":"Kucher N","year":"2011","unstructured":"Kucher N. Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med. 2011, 364:861-9. 10.1056\/NEJMcp1008740","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.06.046","article-title":"Upper extremity deep vein thrombosis: a community-based perspective","volume":"120","author":"Spencer FA","year":"2007","unstructured":"Spencer FA, Emery C, Lessard D, Goldberg RJ. Upper extremity deep vein thrombosis: a community-based perspective. Am J Med. 2007, 120:678-84. 10.1016\/j.amjmed.2006.06.046","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon C","year":"2016","unstructured":"Kearon C, Akl EA, Ornelas J, et al.. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016, 149:315-52. 10.1016\/j.chest.2015.11.026","journal-title":"Chest"},{"key":"ref7","article-title":"Adult Venous Thromboembolism (VTE) Guideline [Internet]","author":"Grant PJ","year":"2024","unstructured":"Grant PJ, Co IN, Lewis S, et al.. Adult Venous Thromboembolism (VTE) Guideline [Internet]. Michigan Medicine University of Michigan, Ann Arbor (MI); 2024."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00257-4","article-title":"Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study","volume":"3","author":"Ageno W","year":"2016","unstructured":"Ageno W, Mantovani LG, Haas S, et al.. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study. Lancet Haematol. 2016, 3:12-21. 10.1016\/S2352-3026(15)00257-4","journal-title":"Lancet Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15559","article-title":"Growth differentiation factor-15 for prediction of bleeding in cancer patients","volume":"20","author":"Mulder FI","year":"2022","unstructured":"Mulder FI, Bosch FT, Carrier M, et al.. Growth differentiation factor-15 for prediction of bleeding in cancer patients. J Thromb Haemost. 2022, 20:138-44. 10.1111\/jth.15559","journal-title":"J Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s100169910084","article-title":"Upper extremity deep venous thrombosis: an underrecognized manifestation of a hypercoagulable state","volume":"14","author":"Hingorani A","year":"2000","unstructured":"Hingorani A, Ascher E, Yorkovich W, Mazzariol F, Jacob T, Gunduz Y, Salles-Cunha S. Upper extremity deep venous thrombosis: an underrecognized manifestation of a hypercoagulable state. Ann Vasc Surg. 2000, 14:421-6. 10.1007\/s100169910084","journal-title":"Ann Vasc Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides SV","year":"2020","unstructured":"Konstantinides SV, Meyer G, Becattini C, et al.. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020, 41:543-603. 10.1093\/eurheartj\/ehz405","journal-title":"Eur Heart J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel TL","year":"2020","unstructured":"Ortel TL, Neumann I, Ageno W, et al.. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020, 4:4693-738. 10.1182\/bloodadvances.2020001830","journal-title":"Blood Adv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2011.441","article-title":"Mortality and cost associated with cardiovascular implantable electronic device infections","volume":"171","author":"Sohail MR","year":"2011","unstructured":"Sohail MR, Henrikson CA, Braid-Forbes MJ, Forbes KF, Lerner DJ. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011, 171:1821-8. 10.1001\/archinternmed.2011.441","journal-title":"Arch Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC guidelines for the management of endocarditis","volume":"44","author":"Delgado V","year":"2023","unstructured":"Delgado V, Ajmone Marsan N, de Waha S, et al.. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023, 44:3948-4042. 10.1093\/eurheartj\/ehad193","journal-title":"Eur Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072069","article-title":"Diagnostic and therapeutic management of upper extremity deep vein thrombosis","volume":"9","author":"Bosch FT","year":"2020","unstructured":"Bosch FT, Nisio MD, B\u00fcller HR, van Es N. Diagnostic and therapeutic management of upper extremity deep vein thrombosis. J Clin Med. 2020, 9:2069. 10.3390\/jcm9072069","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1757937","article-title":"Upper extremity deep venous thrombosis: etiologies, diagnosis, and updates in therapeutic strategies","volume":"39","author":"Koethe Y","year":"2022","unstructured":"Koethe Y, Bochnakova T, Kaufman CS. Upper extremity deep venous thrombosis: etiologies, diagnosis, and updates in therapeutic strategies. Semin Intervent Radiol. 2022, 39:475-82. 10.1055\/s-0042-1757937","journal-title":"Semin Intervent Radiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller HR","year":"2013","unstructured":"B\u00fcller HR, D\u00e9cousus H, Grosso MA, et al.. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med. 2013, 369:1406-15. 10.1056\/NEJMoa1306638","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-742304","article-title":"How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy","volume":"129","author":"Schulman S","year":"2017","unstructured":"Schulman S. How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy. Blood. 2017, 129:3285-93. 10.1182\/blood-2017-03-742304","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/466414-pacemaker-lead-associated-innominate-vein-thrombosis-despite-non-vitamin-k-oral-anticoagulant-noac-therapy-an-incidental-ct-finding","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:27:50Z","timestamp":1772728070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/466414-pacemaker-lead-associated-innominate-vein-thrombosis-despite-non-vitamin-k-oral-anticoagulant-noac-therapy-an-incidental-ct-finding"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.104717","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,5]]}}}